Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes

@inproceedings{Zinman2012InsulinDV,
  title={Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes},
  author={Bernard Zinman and Athena Philis-Tsimikas and Bertrand Cariou and Yehuda Handelsman and Helena W Rodbard and Thue Johansen and Lars A. Endahl and Chantal Mathieu},
  booktitle={Diabetes care},
  year={2012}
}
OBJECTIVE To compare ultra-long-acting insulin degludec with glargine for efficacy and safety in insulin-naive patients with type 2 diabetes inadequately controlled with oral antidiabetic drugs (OADs). RESEARCH DESIGN AND METHODS In this 1-year, parallel-group, randomized, open-label, treat-to-target trial, adults with type 2 diabetes with A1C of 7-10% taking OADs were randomized 3:1 to receive once daily degludec or glargine, both with metformin. Insulin was titrated to achieve prebreakfast… CONTINUE READING
Highly Influential
This paper has highly influenced a number of papers. REVIEW HIGHLY INFLUENTIAL CITATIONS